Evidence map›Paper›PMID 22016510›Full record

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2012

Noninvasive detection of breast cancer lymph node metastasis using carbonic anhydrases IX and XII targeted imaging probes.

Narges K Tafreshi, Marilyn M Bui, Kellsey Bishop, Mark C Lloyd, Steven A Enkemann, Alexis S Lopez, Dominique Abrahams, Bradford W Carter, Josef Vagner, Stephen R Grobmyer and 3 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 41 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 2 pooled it
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 2 syntheses or guidelines pooled it, 90 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Promise of hypoxia-targeted tracers in metastatic lymph node imaging.European journal of nuclear medicine and molecular imaging · 2022
    Article
  8. NSAIDs and Cancer Resolution: New Paradigms beyond Cyclooxygenase.International journal of molecular sciences · 2022
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
    Gobmyer, Stephen R [corrected to Grobmyer, Stephen R]
5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Narges K TafreshiDepartment of Molecular & Functional Imaging, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.
Marilyn M Bui
Kellsey Bishop
Mark C Lloyd
Steven A Enkemann
Alexis S Lopez
Dominique Abrahams
Bradford W Carter
Josef Vagner
Stephen R Grobmyer
Stephen R Gobmyer
Robert J Gillies
David L Morse
Moffitt Cancer Center · USUniversity of Arizona · USUniversity of Florida · USUniversity of South Florida · US

Funding

TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI KENNETH Lynn WRIGHT · 1998 to 2026
$93.5M
Imaging Biomarkers for Response to Anti-Cancer TherapyR01CA125627 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI BAKER, AMANDA F, GILLIES, ROBERT J. · 2008 to 2012
$1.7M
NCI NIH HHS P30 CA076292NCI NIH HHS R01 CA125627
6 · The paper itself

Abstract

purposeTo develop targeted molecular imaging probes for the noninvasive detection of breast cancer lymph node metastasis. EXPERIMENTAL

designSix cell surface or secreted markers were identified by expression profiling and from the literature as being highly expressed in breast cancer lymph node metastases. Two of these markers were cell surface carbonic anhydrase isozymes (CAIX and/or CAXII) and were validated for protein expression by immunohistochemistry of patient tissue samples on a breast cancer tissue microarray containing 47 normal breast tissue samples, 42 ductal carcinoma in situ, 43 invasive ductal carcinomas without metastasis, 46 invasive ductal carcinomas with metastasis, and 49 lymph node macrometastases of breast carcinoma. Targeted probes were developed by conjugation of CAIX- and CAXII-specific monoclonal antibodies to a near-infrared fluorescent dye.

resultsTogether, these two markers were expressed in 100% of the lymph node metastases surveyed. Selectivity of the imaging probes were confirmed by intravenous injection into nude mice-bearing mammary fat pad tumors of marker-expressing cells and nonexpressing cells or by preinjection of unlabeled antibody. Imaging of lymph node metastases showed that peritumorally injected probes detected nodes harboring metastatic tumor cells. As few as 1,000 cells were detected, as determined by implanting, under ultrasound guidance, a range in number of CAIX- and CAXII-expressing cells into the axillary lymph nodes.

conclusionThese imaging probes have potential for noninvasive staging of breast cancer in the clinic and elimination of unneeded surgery, which is costly and associated with morbidities.

Indexed as

Antibodies, MonoclonalDiagnostic ImagingAnimalsAntigens, NeoplasmBiomarkers, TumorBlotting, WesternBreastBreast NeoplasmsCarbonic Anhydrase IXCarbonic AnhydrasesCarcinoma, Ductal, BreastCarcinoma, Intraductal, NoninfiltratingFemaleFluorescent Antibody TechniqueGene Expression ProfilingHumansAntibodies, MonoclonalAntigens, NeoplasmBiomarkers, TumorCA9 protein, humanCarbonic Anhydrase IXCarbonic Anhydrasescarbonic anhydrase XIILuciferasesRNA, Messenger

Identifiers

PMID22016510
PMCPMC4130557
OpenAlexW2166064038

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.